1. Home
  2. ABUS vs OFRM Comparison

ABUS vs OFRM Comparison

Compare ABUS & OFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.24

Market Cap

848.8M

Sector

Health Care

ML Signal

HOLD

OFRM

Once Upon a Farm PBC

N/A

Current Price

$16.02

Market Cap

684.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ABUS
OFRM
Founded
2005
2015
Country
United States
United States
Employees
19
153
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
848.8M
684.3M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
ABUS
OFRM
Price
$4.24
$16.02
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$5.00
$27.75
AVG Volume (30 Days)
1.6M
417.6K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
55.26
N/A
EPS
0.87
N/A
Revenue
$14,083,000.00
N/A
Revenue This Year
N/A
$29.42
Revenue Next Year
$239.71
$34.69
P/E Ratio
$4.95
N/A
Revenue Growth
128.21
N/A
52 Week Low
$3.04
$14.00
52 Week High
$5.10
$27.00

Technical Indicators

Market Signals
Indicator
ABUS
OFRM
Relative Strength Index (RSI) 45.31 50.73
Support Level $4.17 $15.76
Resistance Level $4.62 $17.06
Average True Range (ATR) 0.16 1.05
MACD -0.00 0.26
Stochastic Oscillator 46.23 55.33

Price Performance

Historical Comparison
ABUS
OFRM

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About OFRM Once Upon a Farm PBC

Once Upon a Farm PBC is a provider of baby food products. The company provides childhood nutrition with real, organic, farm-fresh food-made with no added sugar, no preservatives, and nothing artificial. Its products are available at retail customers, including Target, Whole Foods, Kroger, Walmart, Publix, and Wegmans. Its key products include Smoothies, Yogurt, Milk Shakes, Oat Bars, etc.

Share on Social Networks: